By Lucy Piper, medwireNews Reporter
medwireNews: Regardless of treatment modality, effective control of hypercortisolism in patients with bilateral adrenal tumors is key to achieving favorable cardiovascular outcomes, suggests a data analysis of the ENSAT trial.
Read the full story on the Cushing’s Hub website.
Image credit: © Kateryna_Kon / stock.adobe.com
